Replies to post #552424 on $Stock*Shop*Charts*News*Option$

[dDT]

GSK Glaxo shareholders vote on Novartis deal on December 18

On December 18 GlaxoSmithKline (NYSE:GSK) shareholders will vote on the company's planned acquisition of Novartis' (NYSE:NVS) vaccines business, the latter's acquisition of Glaxo's cancer products and the combination of their consumer healthcare businesses. The total value of the assets involved is ~$20B.